Εμφάνιση απλής εγγραφής

dc.creatorSinani O., Dadouli K., Ntellas P., Kapsalaki E.Z., Vlychou M., Raptis D.G., Marogianni C., Markou K., Dardiotis E., Xiromerisiou G.en
dc.date.accessioned2023-01-31T09:56:31Z
dc.date.available2023-01-31T09:56:31Z
dc.date.issued2022
dc.identifier10.1080/01616412.2022.2112378
dc.identifier.issn01616412
dc.identifier.urihttp://hdl.handle.net/11615/79009
dc.description.abstractBackground: White matter hyperintensities (WMHs) may be observed on Magnetic Resonance Imaging (MRI) in patients with Parkinson disease with or without vascular risk factors. Whether WMHs may influence motor and non-motor aspects of Parkinson disease is a subject of debate. The aim of this study is to evaluate the impact of WMH severity on various aspects of Parkinson disease in combination to the estimation of the impact of cerebrovascular risk factors. Materials and Methods: We included a cohort of patients with Parkinson’s disease who underwent MRI examination. The Fazekas visual rating scale was used to assess the severity and location of WMHs, and patient clinical characteristics were correlated with MRI data. Results: All vascular risk factors were associated with higher Fazekas score in both periventricular and deep white matter. Periventricular white matter hyperintensities (PWMHs) and deep white matter hyperintensities (DWMHs) were associated with lower scores in the ACE-R cognitive assessment scale (p < 0.001). Furthermore, PWMHs and DWMHs severity was associated with higher UPDRS motor score (p < 0.001), while the Postural Instability Gait Difficulty (PIGD) phenotype was correlated with higher burden of WMHs. Conclusions: Comorbid WMHs may contribute to multi-dimension dysfunction in patients with Parkinson disease and consequently the management of vascular risk factors may be crucial to maintain motor and non-motor functions in PD. © 2022 Informa UK Limited, trading as Taylor & Francis Group.en
dc.language.isoenen
dc.sourceNeurological Researchen
dc.source.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85136488249&doi=10.1080%2f01616412.2022.2112378&partnerID=40&md5=7e02d224b266db1fe22fbaee9bbe722c
dc.subjectlevodopaen
dc.subjectadulten
dc.subjectArticleen
dc.subjectcognitionen
dc.subjectdiabetes mellitusen
dc.subjectdisease durationen
dc.subjectfemaleen
dc.subjectfluid-attenuated inversion recovery imagingen
dc.subjectgait disorderen
dc.subjecthistopathologyen
dc.subjecthumanen
dc.subjecthuman tissueen
dc.subjecthyperlipidemiaen
dc.subjecthypertensionen
dc.subjectmajor clinical studyen
dc.subjectmaleen
dc.subjectneurologic examinationen
dc.subjectnuclear magnetic resonance imagingen
dc.subjectParkinson diseaseen
dc.subjectphenotypeen
dc.subjectretrospective studyen
dc.subjectrisk factoren
dc.subjectsmokingen
dc.subjectwhite matter lesionen
dc.subjectcognitionen
dc.subjectcomplicationen
dc.subjectdiagnostic imagingen
dc.subjectgaiten
dc.subjectwhite matteren
dc.subjectCognitionen
dc.subjectGaiten
dc.subjectHumansen
dc.subjectParkinson Diseaseen
dc.subjectWhite Matteren
dc.subjectTaylor and Francis Ltd.en
dc.titleAssociation between white matter lesions and Parkinson’s disease: an impact on Postural/Gait difficulty phenotype and cognitive performanceen
dc.typejournalArticleen


Αρχεία σε αυτό το τεκμήριο

ΑρχείαΜέγεθοςΤύποςΠροβολή

Δεν υπάρχουν αρχεία που να σχετίζονται με αυτό το τεκμήριο.

Αυτό το τεκμήριο εμφανίζεται στις ακόλουθες συλλογές

Εμφάνιση απλής εγγραφής